As of Nov 15
| -0.0823 / -8.07%|
The 4 analysts offering 12-month price forecasts for Oncolytics Biotech Inc have a median target of 8.15, with a high estimate of 9.00 and a low estimate of 6.80. The median estimate represents a +769.43% increase from the last price of 0.94.
The current consensus among 4 polled investment analysts is to Buy stock in Oncolytics Biotech Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.